Back to Search Start Over

Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.

Authors :
Zhang YY
Peng J
Luo XJ
Source :
Biochemical pharmacology [Biochem Pharmacol] 2022 Apr; Vol. 198, pp. 114977. Date of Electronic Publication: 2022 Feb 23.
Publication Year :
2022

Abstract

Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is a multifunctional protein. MALT1 functions as an adaptor protein to assemble and recruit proteins such as B-cell lymphoma 10 (BCL10) and caspase-recruitment domain (CARD)-containing coiled-coil protein 11 (CARD11). Conversely it also acts as a paracaspase to cleave specified substrates. Because of its involvement in immunity, inflammation and cancer through its dual functions of scaffolding and catalytic activity, MALT1 is becoming a promising therapeutic target in B cell- and T cell-related diseases. There is growing evidence that the function of MALT1 is subtly modulated via post-translational modifications. This review summarized recent progress in relevant studies regarding the physiological and pathophysiological functions of MALT1, post-translational modifications of MALT1 and its role in B cell- and T cell- related diseases. In addition, the current available MALT1 inhibitors were also discussed.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1873-2968
Volume :
198
Database :
MEDLINE
Journal :
Biochemical pharmacology
Publication Type :
Academic Journal
Accession number :
35218741
Full Text :
https://doi.org/10.1016/j.bcp.2022.114977